These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 16876392)

  • 21. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of drug particle size in ultrasound compacted tablets. Continuum percolation model approach.
    Millán M; Caraballo I
    Int J Pharm; 2006 Mar; 310(1-2):168-74. PubMed ID: 16431046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
    Reza MS; Quadir MA; Haider SS
    J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets.
    Viridén A; Wittgren B; Larsson A
    Eur J Pharm Sci; 2009 Feb; 36(2-3):297-309. PubMed ID: 19038336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of HPMC particle size on the drug release rate and the percolation threshold in extended-release mini-tablets.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2015 Jan; 41(1):70-8. PubMed ID: 24134563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of controlled release inert matrices of naltrexone hydrochloride based on percolation concepts.
    Caraballo I; Melgoza LM; Alvarez-Fuentes J; Soriano MC; Rabasco AM
    Int J Pharm; 1999 Apr; 181(1):23-30. PubMed ID: 10370199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained delivery of captopril from floating matrix tablets.
    Jiménez-Martínez I; Quirino-Barreda T; Villafuerte-Robles L
    Int J Pharm; 2008 Oct; 362(1-2):37-43. PubMed ID: 18588962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Release kinetics of highly porous floating tablets containing cilostazol.
    Hwang KM; Cho CH; Tung NT; Kim JY; Rhee YS; Park ES
    Eur J Pharm Biopharm; 2017 Jun; 115():39-51. PubMed ID: 28219750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
    Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multivariate statistical approach to optimizing sustained-release tablet formulations containing diltiazem hydrochloride as a model highly water-soluble drug.
    Kikuchi S; Takayama K
    Int J Pharm; 2010 Feb; 386(1-2):149-55. PubMed ID: 19922778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a robust once-a-day glipizide matrix system.
    Jamzad S; Fassihi R
    J Pharm Pharmacol; 2007 Jun; 59(6):769-75. PubMed ID: 17637169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymer mobilization and drug release during tablet swelling. A 1H NMR and NMR microimaging study.
    Dahlberg C; Fureby A; Schuleit M; Dvinskikh SV; Furó I
    J Control Release; 2007 Sep; 122(2):199-205. PubMed ID: 17706829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of khaya gum as a directly compressible matrix system for controlled release.
    Odeku OA; Fell JT
    J Pharm Pharmacol; 2004 Nov; 56(11):1365-70. PubMed ID: 15525442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of sodium dodecyl sulfate on swelling, erosion and release behavior of HPMC matrix tablets containing a poorly water-soluble drug.
    Zeng A; Yuan B; Fu Q; Wang C; Zhao G
    Pharm Dev Technol; 2009; 14(5):499-505. PubMed ID: 19743948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Designing HPMC matrices with improved resistance to dissolved sugar.
    Williams HD; Ward R; Culy A; Hardy IJ; Melia CD
    Int J Pharm; 2010 Nov; 401(1-2):51-9. PubMed ID: 20858538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Release behaviour of clozapine matrix pellets based on percolation theory.
    Aguilar-de-Leyva A; Sharkawi T; Bataille B; Baylac G; Caraballo I
    Int J Pharm; 2011 Feb; 404(1-2):133-41. PubMed ID: 21094234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Description of the release of sodium ferulate from hydroxypropyl methylcellulose based matrix tablets in vitro].
    Li FQ; Hu JH
    Yao Xue Xue Bao; 2004 May; 39(5):389-91. PubMed ID: 15338886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of ethanol on aspirin release from hypromellose matrices.
    Roberts M; Cespi M; Ford JL; Dyas AM; Downing J; Martini LG; Crowley PJ
    Int J Pharm; 2007 Mar; 332(1-2):31-7. PubMed ID: 17084050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug release kinetic analysis and prediction of release data via polymer molecular weight in sustained release diltiazem matrices.
    Adibkia K; Ghanbarzadeh S; Mohammadi G; Khiavi HZ; Sabzevari A; Barzegar-Jalali M
    Drug Res (Stuttg); 2014 Mar; 64(3):118-23. PubMed ID: 23986307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
    Marinich JA; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.